Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma.

Sara A MansfieldM Beth McCarvilleJohn T LucasMatthew J KrasinSara M FedericoVictor M SantanaWayne L FurmanAndrew M Davidoff

Published in: Annals of surgical oncology (2021)

Neoadjuvant chemotherapy reduced the number of IDRFs in the majority of patients with high-risk neuroblastoma. The number of IDRFs present after neoadjuvant therapy correlated with the extent of resection.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
risk factors
rectal cancer
sentinel lymph node
squamous cell carcinoma
radiation therapy
deep learning
stem cells
early stage